PROSTATE CANCER

Final SPARTAN data show OS benefit

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

Original article

  1. Smith, M. R. et al. Apalutamide and overall survival in prostate cancer. Eur. Urol. https://doi.org/10.1016/j.eururo.2020.08.011 (2020)

    Article  PubMed  PubMed Central  Google Scholar 

Related article

  1. Schmid, S. & Omlin, A. Progress in therapy across the spectrum of advanced prostate cancer. Nat. Rev. Urol. 17, 71–72 (2020)

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Annette Fenner.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fenner, A. Final SPARTAN data show OS benefit. Nat Rev Urol 17, 602 (2020). https://doi.org/10.1038/s41585-020-00381-w

Download citation

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing